Lung carcinoma tissue microarray, 4 cores per case. Pathology grade, TNM Classification, and Clinical Stages information available.
- 2 cases of invasive adenocarcinoma
- 11 cases of papillary adenocarcinoma
- 7 cases of solid adenocarcinoma
- 2 cases of lepidic predominant adenocarcinoma
- 26 cases of acinar adenocarcinoma
Price
$255.00
Catalogue No | RLN04017c |
Species | Human |
Fixative | Formalin |
Total Cases | 48 |
Total Cores | 96 |
Core Diameter | 1 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
G | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
H | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 43 | M | Lung | Acinar adenocarcinoma | 1 | T2aN0M0 | IB | Malignant |
2 | A2 | 43 | M | Lung | Acinar adenocarcinoma | 1 | T2aN0M0 | IB | Malignant |
3 | A3 | 53 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
4 | A4 | 53 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
5 | A5 | 59 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
6 | A6 | 59 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
7 | A7 | 69 | M | Lung | Acinar adenocarcinoma | 2 | T2bN2M0 | IIIA | Malignant |
8 | A8 | 69 | M | Lung | Acinar adenocarcinoma | 2 | T2bN2M0 | IIIA | Malignant |
9 | A9 | 59 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
10 | A10 | 59 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
11 | A11 | 58 | F | Lung | Acinar adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant |
12 | A12 | 58 | F | Lung | Acinar adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant |
13 | B1 | 62 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
14 | B2 | 62 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
15 | B3 | 65 | F | Lung | Acinar adenocarcinoma | 2 | T2bN2M0 | IIIA | Malignant |
16 | B4 | 65 | F | Lung | Acinar adenocarcinoma | 2 | T2bN2M0 | IIIA | Malignant |
17 | B5 | 55 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
18 | B6 | 55 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
19 | B7 | 50 | M | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
20 | B8 | 50 | M | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
21 | B9 | 64 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
22 | B10 | 64 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
23 | B11 | 39 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
24 | B12 | 39 | F | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
25 | C1 | 48 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
26 | C2 | 48 | M | Lung | Acinar adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
27 | C3 | 62 | F | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
28 | C4 | 62 | F | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
29 | C5 | 46 | F | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
30 | C6 | 46 | F | Lung | Acinar adenocarcinoma | 2 | T1aN0M0 | IA | Malignant |
31 | C7 | 59 | M | Lung | Acinar adenocarcinoma | 2--3 | T2bN0M0 | IIA | Malignant |
32 | C8 | 59 | M | Lung | Acinar adenocarcinoma | 2--3 | T2bN0M0 | IIA | Malignant |
33 | C9 | 56 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN1M0 | IIA | Malignant |
34 | C10 | 56 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN1M0 | IIA | Malignant |
35 | C11 | 54 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
36 | C12 | 54 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
37 | D1 | 65 | M | Lung | Acinar adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
38 | D2 | 65 | M | Lung | Acinar adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
39 | D3 | 70 | M | Lung | Acinar adenocarcinoma | 3 | T4N2M0 | IIIB | Malignant |
40 | D4 | 70 | M | Lung | Acinar adenocarcinoma | 3 | T4N2M0 | IIIB | Malignant |
41 | D5 | 66 | M | Lung | Acinar adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
42 | D6 | 66 | M | Lung | Acinar adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
43 | D7 | 57 | F | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
44 | D8 | 57 | F | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
45 | D9 | 70 | M | Lung | Acinar adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
46 | D10 | 70 | M | Lung | Acinar adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
47 | D11 | 48 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
48 | D12 | 48 | M | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
49 | E1 | 58 | F | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
50 | E2 | 58 | F | Lung | Acinar adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
51 | E3 | 65 | M | Lung | Acinar adenocarcinoma | 3 | T2aN2M0 | IIIA | Malignant |
52 | E4 | 65 | M | Lung | Acinar adenocarcinoma | 3 | T2aN2M0 | IIIA | Malignant |
53 | E5 | 54 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
54 | E6 | 54 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
55 | E7 | 41 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
56 | E8 | 41 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
57 | E9 | 52 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
58 | E10 | 52 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
59 | E11 | 65 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
60 | E12 | 65 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
61 | F1 | 58 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
62 | F2 | 58 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
63 | F3 | 57 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
64 | F4 | 57 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
65 | F5 | 61 | F | Lung | Papillary adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
66 | F6 | 61 | F | Lung | Papillary adenocarcinoma | 2 | T2aN1M0 | IIA | Malignant |
67 | F7 | 52 | F | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
68 | F8 | 52 | F | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
69 | F9 | 50 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
70 | F10 | 50 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
71 | F11 | 52 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
72 | F12 | 52 | M | Lung | Papillary adenocarcinoma | 2 | T2bN0M0 | IIA | Malignant |
73 | G1 | 70 | M | Lung | Papillary adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
74 | G2 | 70 | M | Lung | Papillary adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
75 | G3 | 62 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
76 | G4 | 62 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
77 | G5 | 45 | F | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
78 | G6 | 45 | F | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
79 | G7 | 69 | M | Lung | Solid adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
80 | G8 | 69 | M | Lung | Solid adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
81 | G9 | 43 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
82 | G10 | 43 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
83 | G11 | 52 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
84 | G12 | 52 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
85 | H1 | 70 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
86 | H2 | 70 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
87 | H3 | 51 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
88 | H4 | 51 | M | Lung | Solid adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
89 | H5 | 62 | M | Lung | Lepidic predominant adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
90 | H6 | 62 | M | Lung | Lepidic predominant adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
91 | H7 | 44 | F | Lung | Lepidic predominant adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
92 | H8 | 44 | F | Lung | Lepidic predominant adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
93 | H9 | 62 | M | Lung | Invasive adenocarcinoma | - | T2aN0M0 | IB | Malignant |
94 | H10 | 62 | M | Lung | Invasive adenocarcinoma | - | T2aN0M0 | IB | Malignant |
95 | H11 | 56 | F | Lung | Invasive mucinous adenocarcinoma | 2--3 | T2bN1M0 | IIB | Malignant |
96 | H12 | 56 | F | Lung | Invasive mucinous adenocarcinoma | 2--3 | T2bN1M0 | IIB | Malignant |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |